Understand the source comparison
Best 5-Amino-1MQ Dosage NNMT Inhibitor 2026: Protocol Comparison
Before selecting a dosing schedule, compare the three most common protocol structures used in 2026 research applications. Conservative Single-Dose 50mg once daily Once daily (morning) 8–12 weeks Initial NNMT suppression studies; low-intervention models Subopti
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting a dosing schedule, compare the three most common protocol structures used in 2026 research applications.
- Conservative Single-Dose
- 50mg once daily
- Once daily (morning)
- 8–12 weeks
- Initial NNMT suppression studies; low-intervention models
- Suboptimal for sustained inhibition. Enzyme activity rebounds within 10–12 hours, creating cyclic suppression rather than continuous inhibition
- Standard Split-Dose
- 75–100mg split (37.5–50mg per dose)
- Twice daily (morning + evening, 8–12 hours apart)
- Metabolic research, NAD+ bioavailability studies, adipocyte differentiation models
- Gold standard. Maintains enzyme suppression across waking hours; aligns with enzyme kinetics and tissue half-life data
- High-Dose Intensive
- 150mg split (75mg per dose)
- 6–8 weeks
- Acute intervention studies requiring maximal NNMT suppression
- No additional benefit over 100mg daily; increases methylation pathway stress without proportional NAD+ gain. Use only when justified by specific research endpoints
- The standard split-dose protocol (75–100mg daily, twice-daily administration) consistently produces the most reliable NNMT suppression across published pre-clinical models. Higher doses do not overcome the compound's inherent limitations. NNMT is one enzyme in a complex metabolic network, and saturating it beyond 70–80% inhibition does not linearly increase downstream effects.